Showing 361 - 370 of 1362 results

Showing Results for: “diabetes”

American Diabetes Association® Announces Step Out DC Honorary Chair

The American Diabetes Association® (ADA) is pleased to announce Emmy Award winning journalist, Michelle Marsh of ABC7 as the honorary chair for this year's Virtual Step Out DC. The event is taking place on Saturday, September 26, 2020. The ADA encourages everyone to walk 3.4 miles in support of the 34 million Americans living with diabetes. It is more important than ever to raise awareness around the diabetes epidemic that is ravishing our communities. We will celebrate and honor those thriving with diabetes while helping to propel the mission of the ADA. “I’m thrilled to be serving as the

The American Diabetes Association Hosting Annual Step Out: Houston

On November 15, the American Diabetes Association ® (ADA) is hosting its flagship fundraising event of the year at the Water Works in Buffalo Bayou Park to raise awareness and provide critical support for those affected by diabetes. Step Out ®: Houston will bring together the diabetes community, volunteers, and advocates for a walk for people of all ages and abilities. The walk benefits diabetes research, education, management, and prevention, supporting the ADA’s mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. Increasingly, this includes those

The American Diabetes Association Hosting Annual Step Out: Pittsburgh

On September 13, the American Diabetes Association ® (ADA) is hosting its flagship fundraising event of the year at the PNC Park Riverwalk to raise awareness and provide critical support for those affected by diabetes. Step Out ®: Pittsburgh will bring together the diabetes community, volunteers, and advocates for a walk for people of all ages and abilities. Approximately 1,183,000 adults in Pennsylvania, or 10% of the adult population, have diagnosed diabetes. Every year, an estimated 91,000 adults in Pennsylvania are diagnosed with diabetes. The walk benefits diabetes research, education

Once Weekly Drug Helps Control Pediatric Type 2 Diabetes

Data Shows Potential Breakthrough Treatment Option for Glucose Management in Adolescents with Uncontrolled Diabetes Findings from an international study show a once-weekly injection of dulaglutide was superior in improving glycemic control in youth with type 2 diabetes compared to placebo. The trial was presented at the 82nd Scientific Sessions of the American Diabetes Association ® (ADA) in New Orleans, LA, and simultaneously published in The New England Journal of Medicine. The findings come at a time when cases of type 2 diabetes among youth have more than doubled, since the pandemic

The American Diabetes Association Hosting Annual Step Out: Philadelphia

On November 8, the American Diabetes Association ® (ADA) is hosting its flagship fundraising event of the year at the Philadelphia Navy Yard to raise awareness and provide critical support for those affected by diabetes. Step Out ® Walk: Philadelphia will bring together the diabetes community, volunteers, and advocates for a walk for people of all ages and abilities. The walk benefits diabetes research, education, management, and prevention, supporting the ADA’s mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. Increasingly, this includes those

American Diabetes Association® Feb. 27 Statement on COVID-19

The ADA has resources for people with diabetes at diabetes.org/coronoavirus The CDC has determined that COVID-19 is a serious public health threat. In general people with diabetes face greater risks of complications when dealing with viral infections like flu, and that is likely to be true with COVID-19. Recommended safety precautions are the same as for flu, such as frequent hand washing and covering coughs and sneezes with a tissue. The CDC does not recommend the use of face masks by people who are not infected. The American Diabetes Association (ADA) encourages people with diabetes to

The American Diabetes Association® Launches: Better Choices for Life

Participating, approved products will display the mark on select products to inform consumers The American Diabetes Association (ADA) is pleased to announce the launch of the Better Choices for Life program. The program is designed to aid shoppers in making better choices while shopping and is currently in its pilot stage. Products are selected through a science and evidence-based approach. At this time, prescription drugs are not evaluated or considered for the program. Following an extensive evaluation process, companies applying for participation and passing the evaluation may place the

American Diabetes Association Unveils #HealthEquityNow Platform to Ignite Action

As COVID-19 puts people with diabetes and minorities in the crosshairs, ADA calls for a Health Equity Bill of Rights to address systemic health inequities The American Diabetes Association® (ADA), the nation’s leading organization for all people living with diabetes, announced today the launch of #HealthEquityNow, a national platform to ensure that all people living with diabetes, and the millions of underserved Americans who are at greatest risk for diabetes, have access to health resources that are too often unavailable to them. The ADA calls on businesses, policymakers, philanthropies and

The American Diabetes Association Launches a New Obesity Division

Today, the American Diabetes Association ® (ADA) announced the launch of the Obesity Association. A division of the ADA, the Obesity Association aims to reduce the prevalence of obesity and improve health outcomes. “As part of our mission to prevent diabetes, it is important that we have an even greater focus on addressing one of the key risk factors for type 2 diabetes, obesity. With nearly half of Americans living with diabetes or prediabetes, we must lean into prevention and a holistic approach to health,” said Charles “Chuck” Henderson, the ADA’s chief executive officer. The ADA has been

American Diabetes Association Statement on FDA Approval of Teplizumab

“This is an historic moment for all people affected by type 1 diabetes (T1D). The approval of Teplizumab, the first-ever treatment approved for the delay of T1D, is a significant step forward for everyone impacted by this chronic disease. People with T1D require life-long insulin replacement therapy, so to be able to provide an individual with a 2-year delay from the symptoms and burden of T1D is a tremendous accomplishment as we look towards finding a cure. There will likely be long-term benefits for blood glucose management and the reduction or delay of acute and long-term complications. The